Device Trial Radar · NCT00622531
Serial BNP Testing for Heart Failure Management
Last checked: Nov 20, 2026Latest source record: Nov 17, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
108
Actual
Start
Jan 2007
Primary completion
Jul 2009
Study completion Jul 2009
Sponsor
- Lead sponsor
- Siemens Healthcare Diagnostics IncPublic (SHL.DE)
- Sponsor type
- Industry
- First posted
- Feb 25, 2008
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The scope of the USE-BNP Trial is to investigate whether knowledge of BNP measurements, in conjunction with clinical assessment, in the outpatient setting can guide the management of therapy in patients with heart failure.
Conditions
- Heart Failure
Interventions
BNP assay (Siemens ADVIA Centaur BNP)Device
Diagnostic test
hidden BNP valueOther
no intervention
Primary outcomes
What the sponsor says the trial is designed to measure.
- composite endpoint of all cause mortality, hospitalization due to worsening heart failure and administration of IV drug therapy for worsening heart failure.Time frame: 12 months
Locations
11 sites in 2 countries. Site status is shown where the registry gives one.
Palo Alto VA Health Care System
Palo Alto, California
10 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.